Skip to main content

Top Left Menu

  • Careers
  • Media
  • Investors

What are you looking for?

Home

You are here

Galderma Global

Choose another location

  • Argentina
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Czech Republic
  • Denmark
  • Finland
  • France
  • Germany
  • Hong Kong/Macau SAR, China
  • India
  • Italy
  • Japan
  • Kingdom of Saudi Arabia
  • Korea
  • Mainland China
  • Mexico
  • Middle East
  • Netherlands
  • Nordic
  • Norway
  • Poland
  • Portugal
  • Russia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan
  • Thailand
  • United Kingdom
  • United States
  • Venezuela

Top menu

  • Contact us
  • Search

Main navigation

  • About us
    • At a glance
    • Our purpose
    • Our strategy
    • Injectable Aesthetics
    • Dermatological Skincare
    • Therapeutic Dermatology
    • Global presence
    • Executive Committee
    • Governance
    • Annual Report 2024
    • The aesthetic impact of medication-driven weight loss
  • Skin Stories
    • Galderma skin stories
    • Skin Science
    • Beauty x Medicine
    • Podcasts
  • Innovation
    • Skin Science by Galderma
    • Bringing innovation to life
    • Partnering
    • Manufacturing
    • Early Access
  • Our brands
  • Sustainability
    • For our employees
    • For patients and consumers
    • For healthcare professionals and customers
    • For society
    • Governance oversight
    • Funding request for education and support activities
    • Our ESG Index
  • Media
  • Careers
  • Home
  • Investors

Japan

Member for

8 years
Submitted by Site Factory admin on Thu, 07/16/2020 - 19:46
  • Read more about Japan

Address:   Galdemra KK (Japan)

                   Across Meguro Tower, 3-5-8 Kami-Osaki

                   Shinagawa-ku, 141-0021 Japan

Email:        safety-inbox.JPTYO@galderma.com

Website:    https://www.galderma.com/jp/

Quality and Pharmacovigilance

Jordan

Member for

8 years
Submitted by Site Factory admin on Thu, 07/16/2020 - 19:45
  • Read more about Jordan

See United Arab Emirates

Quality and Pharmacovigilance

Kazakhstan

Member for

8 years
Submitted by Site Factory admin on Thu, 07/16/2020 - 19:45
  • Read more about Kazakhstan

See Russia

Quality and Pharmacovigilance

Kingdom of Saudi Arabia

Member for

8 years
Submitted by Site Factory admin on Thu, 07/16/2020 - 19:43
  • Read more about Kingdom of Saudi Arabia

See United Arab Emirates

Quality and Pharmacovigilance

Kuwait

Member for

8 years
Submitted by Site Factory admin on Thu, 07/16/2020 - 19:43
  • Read more about Kuwait

See United Arab Emirates

Quality and Pharmacovigilance

Laos

Member for

8 years
Submitted by Site Factory admin on Thu, 07/16/2020 - 19:42
  • Read more about Laos

See Singapore

Quality and Pharmacovigilance

Lebanon

Member for

8 years
Submitted by Site Factory admin on Thu, 07/16/2020 - 19:42
  • Read more about Lebanon

See United Arab Emirates

Quality and Pharmacovigilance

Lichstenstein

Member for

8 years
Submitted by Site Factory admin on Thu, 07/16/2020 - 19:41
  • Read more about Lichstenstein

See Switzerland

Quality and Pharmacovigilance

Luxembourg

Member for

8 years
Submitted by Site Factory admin on Thu, 07/16/2020 - 19:41
  • Read more about Luxembourg

See The Netherlands

Quality and Pharmacovigilance

Macau

Member for

8 years
Submitted by Site Factory admin on Thu, 07/16/2020 - 19:40
  • Read more about Macau

See Hong Kong

Quality and Pharmacovigilance

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Current page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
  1. Home

STAY CONNECTED

Follow us on Social Media for current news and patients stories

Instagram LinkedIn Icon Twitter Icon
© Galderma 2025

Footer menu 2

  • Terms of use
  • Cookie Policy
  • Privacy
  • Sitemap

Confirm navigation

You are about to leave the Galderma global site. Are you sure you want to leave this page?

Yes, thanks Go back